Numerous prospective studies utilizing the HOMA-IR index to assess IR demonstrate that IR substantially increases individual diabetes or CVD risk in patients with CMS, suggesting that CMS does not equate to an insulin-resistant phenotype [32–34]. This evidence concerns the gene INS and diabetes mellitus.